Concordance between Anti-Factor Xa and Activated Partial Thromboplastin Time Measurements in Syncardia Total Artificial Heart Recipients Receiving Postoperative Anticoagulation with Unfractionated Heparin

被引：0
|
作者：
Vela, M. Monteagudo [1 ]
Bowles, C. [1 ]
Raj, B. [1 ]
Simon, A. [1 ]
机构：
[1] Harefield Hosp, Cardiothorac Transplantat & Mech Circulatory Supp, London, England
来源：
JOURNAL OF HEART AND LUNG TRANSPLANTATION | 2020年 / 39卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1133
引用
收藏
页码：S447 / S447
页数：1
相关论文
共 50 条
  • [21] Agreement between activated partial thromboplastin time and anti-Xa activity in critically ill patients receiving therapeutic unfractionated heparin
    Ratano, Damian
    Alberio, Lorenzo
    Delodder, Frederik
    Faouzi, Mohamed
    Berger, Mette M.
    THROMBOSIS RESEARCH, 2019, 175 : 53 - 58
  • [22] Performance of Anti-Factor Xa Versus Activated Partial Thromboplastin Time for Heparin Monitoring Using Multiple Nomograms
    Whitman-Purves, Emily
    Coons, James C.
    Miller, Taylor
    DiNella, Jeannine V.
    Althouse, Andrew
    Schmidhofer, Mark
    Smith, Roy E.
    CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS, 2018, 24 (02) : 310 - 316
  • [23] Retrospective cohort study comparing activated partial thromboplastin time versus anti-factor Xa activity nomograms for therapeutic unfractionated heparin monitoring in pediatrics
    Trucco, M.
    Lehmann, C. U.
    Mollenkopf, N.
    Streiff, M. B.
    Takemoto, C. M.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2015, 13 (05) : 788 - 794
  • [24] Anti-factor Xa and activated partial thromboplastin time strategies for unfractionated heparin dosing after HeartMate 3 left ventricular assist device implantation
    Feng, Iris
    Kurlansky, Paul A.
    Powley, Tanner R.
    Hynds, Melissa A.
    Yang, Christine G.
    Eisenberger, Andrew
    Hastie, Jonathan M.
    Sutherland, Lauren D.
    Yuzefpolskaya, Melana
    Colombo, Paolo C.
    Sayer, Gabriel T.
    Uriel, Nir Y.
    Naka, Yoshifumi
    Takeda, Koji
    ARTIFICIAL ORGANS, 2024,
  • [25] Anti-factor Xa Levels Versus Activated Partial Thromboplastin Time for Monitoring Unfractionated Heparin in Patients with Continuous Flow Left Ventricular Assist Devices
    Yarmohammadi, H.
    Holley, C.
    Thennapin, T.
    Duval, S.
    Pritzker, M.
    Cogswell, R.
    John, R.
    Colvin-Adams, M.
    Eckman, P.
    Adatya, S.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2014, 33 (04): : S23 - S24
  • [26] Basis for Biochemical Discordance Between Activated Partial Thromboplastin Time and Anti-factor Xa in Patients with Continuous Flow Left Ventricular Assist Device on Unfractionated Heparin Infusion
    Yarmohammadi, Hirad
    Feng, Amy J.
    Alraies, Chadi M.
    Thenappan, Thenappan
    Colvin, Monica
    John, Ranjit
    Eckman, Peter
    Pritzker, Marc
    Adatya, Sirtaz
    CIRCULATION, 2014, 130
  • [27] Comparison of anti-factor Xa heparin activity and activated partial thromboplastin time in 2,773 plasma samples from unfractionated heparin-treated patients
    Rosborough, TK
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 1997, 108 (06) : 662 - 668
  • [28] Anti-factor Xa activity, prothrombin time, and activated partial thromboplastin time in patients treated with factor Xa inhibitors
    Ono, Ryohei
    Nishimura, Kazutaka
    Takahashi, Hidehisa
    Hori, Yasuhiko
    Fukushima, Kenichi
    Kobayashi, Yoshio
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2023, 396 (02) : 323 - 336
  • [29] Anti-factor Xa activity, prothrombin time, and activated partial thromboplastin time in patients treated with factor Xa inhibitors
    Ryohei Ono
    Kazutaka Nishimura
    Hidehisa Takahashi
    Yasuhiko Hori
    Kenichi Fukushima
    Yoshio Kobayashi
    Naunyn-Schmiedeberg's Archives of Pharmacology, 2023, 396 : 323 - 336
  • [30] Discordance in activated partial thromboplastin time and anti-factor Xa levels in COVID-19 patients on heparin therapy
    Lawlor, Matthew
    Gupta, Aakriti
    Ranard, Lauren S.
    Madhavan, Mahesh V.
    Li, Jianhua
    Eisenberger, Andrew
    Parikh, Sahil A.
    Sethi, Sanjum S.
    Masoumi, Amirali
    THROMBOSIS RESEARCH, 2021, 198 : 79 - 82
12345